Skip to content
Provepharm

Provepharm

Biotech·France·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Provepharm?

Provepharm is currently owned by ARCHIMED through MED II (2017 vintage), since 2018. Across its history, Provepharm has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

ARCHIMED
Most recent investor
ARCHIMED
MED II · 2017 · Buyout
2 ownership periods · full history below

Key facts

HQFrance
SectorBiotech

Ownership history

2 ownership periods

Active
Currently held by ARCHIMED since 2018.
SOFIPACA - Groupe Crédit Agricole
2011 · 2018(7yr) · SOFIPACA Evergreen · 1991 · Growth
Secondary · to
MOIC
ARCHIMED
ARCHIMEDActive
2018 · present(8yr) · MED II · 2017 · Buyout
Track Provepharm

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Provepharm?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Provepharm.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue